Edgewell Personal Care

At the Barclays conference Edgewell said the multi-year restructuring is largely complete and the company is now entering a growth and simplification phase. North America showed organic growth in the third quarter, market share was regained, and management expects the fourth quarter to be the strongest of the year for organic revenue growth and gross margin. Going forward the company will focus on automation, system harmonization and the use of AI, while plant consolidations, tariffs and higher raw material costs are causing short-term headwinds. After the sale of the feminine care business, Edgewell sees greater financial flexibility and expects free cash flow to improve once one-off costs subside. » Mere på de.investing.com

Edgewell reported Q3 fiscal 2026 organic net sales growth driven by improved North America performance and strength in Sun Care, Grooming and branded Wet Shave. Adjusted EPS and adjusted EBITDA exceeded expectations while adjusted gross margin was in line with guidance; management expects stronger Q4 and left full‑year adjusted EPS and EBITDA midpoint unchanged. Company highlighted progress from its Feminine Care divestiture, expanded brand investments (Hawaiian Tropic, Cremo, Billie), and ongoing Wet Shave manufacturing consolidation to drive future productivity, margin and cash flow improvements. » Mere på finance.yahoo.com

Edgewell reported adjusted EPS of $0.72 for Q3 2026, beating the consensus expectation of $0.63, while revenue of $570.1 million narrowly missed the forecast of $578.09 million. Organic net sales rose 1.1%, driven by a 3.0% increase in North America, while international sales fell 1.4%. Adjusted operating income declined year-over-year, but management remained confident for the full year, reaffirmed its annual targets and expects a stronger fourth quarter and margin improvement in 2027. » Mere på de.investing.com